Vas Narasimhan

Novartis CEO Vas Narasimhan said AI is helping speed up drug discovery timelines, as the pharma giant reported second-quarter earnings that topped estimates. Novartis stock rose Tuesday after the earn…

Anthropic launched its own drug discovery programs targeting neglected diseases that Big Pharma deems unprofitable. Novartis CEO Vas Narasimhan noted AI could cut development time from twelve to seven…